Literature DB >> 10604605

Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors.

A S Lieu1, S L Howng.   

Abstract

In a retrospective study of a consecutive series of 222 surgically treated meningiomas, it was found that 26.6% of the patients presented epilepsy as their initial symptom. In this group, surgical excision of the intracranial meningiomas stopped the epilepsy in about 62.7% of the patients. But approximately one-fifth of the patients with intracranial meningiomas and no history of preoperative epilepsy developed new onset postoperative seizures. Of the patients with early onset of postoperative epilepsy, epilepsy appeared in 66.7% within first 48 h after surgery. Of the patients with postoperative epilepsy, 71.2% were seizure-free following 1 year of anticonvulsant therapy. Regarding preoperative existing factors, intracranial meningiomas located at supratentorium, convexity, and with evidence of or severe peritumoral edema significantly contributed to preoperative epilepsy. And in patients with preoperative epilepsy, those tumors with evidence of or severe perifocal edema and cerebral edema at the operative site were significantly more likely to suffer from postoperative epilepsy.

Entities:  

Mesh:

Year:  2000        PMID: 10604605     DOI: 10.1016/s0920-1211(99)00066-2

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  33 in total

1.  Prophylactic antiepileptic drugs in patients with brain tumors.

Authors:  Donna C Bergen
Journal:  Epilepsy Curr       Date:  2005 Sep-Oct       Impact factor: 7.500

2.  25-year-old woman with new-onset seizures.

Authors:  Peter L Konieczny; Ronald Reimer
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

Review 3.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

4.  Clinical multifactorial analysis of early postoperative seizures in elderly patients following meningioma resection.

Authors:  B O Zhang; Dan Wang; Yunbao Guo; Jinlu Yu
Journal:  Mol Clin Oncol       Date:  2015-01-22

5.  Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas.

Authors:  Rohit R Das; Elinor Artsy; Shelley Hurwitz; Patrick Y Wen; Peter Black; Alexandra Golby; Barbara Dworetzky; Jong Woo Lee
Journal:  J Neurooncol       Date:  2012-01-03       Impact factor: 4.130

Review 6.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

7.  Prediction of Histological Grade and Completeness of Resection of Intracranial Meningiomas: Role of Peritumoural Brain Edema.

Authors:  Kamalanathan Palaniandy; Mohammad Saffari Mohammad Haspani; Norzaini Rose Mohd Zain
Journal:  Malays J Med Sci       Date:  2017-06-30

8.  Predicting outcome of epilepsy after meningioma resection.

Authors:  Hans-Georg Wirsching; Corinne Morel; Corinne Gmür; Marian Christoph Neidert; Christian Richard Baumann; Antonios Valavanis; Elisabeth Jane Rushing; Niklaus Krayenbühl; Michael Weller
Journal:  Neuro Oncol       Date:  2015-12-18       Impact factor: 12.300

9.  Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study.

Authors:  Zhe Zheng; Peng Chen; Weiming Fu; Junming Zhu; Hong Zhang; Jian Shi; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-24       Impact factor: 4.130

10.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.